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Factors Influencing Show Rates at an Outreach Clinic in an Underserved Community Sebastian Sylvestre, MD, Nancy Linebaugh, RRT, Tracy B. Fausnight, MD FAAAAI, and Doerthe A. Andreae, MD PhD; Penn State Hershey Medical Center, Hershey, PA. RATIONALE: Lack of patient adherence to medical appointment times leads to delayed or absent care, increased cost, and is detrimental to patients, physicians, and health care institutions. This study investigates interventions/factors influencing show rates at an underserved community pediatric Allergy/Immunology outreach clinic. METHODS: Over a 10 week period, 97 patient appointments were included in the analysis. For the final five weeks, all patients received personal reminder phone calls two days prior to appointment times. Additionally, the following factors were compared: new versus return appointment, morning versus afternoon appointment, distance to clinic, and type of insurance. RESULTS: Reminder phone calls increased patient show rates to 54.7% from 47.7% (p-value 0.498). In the total 10 week period, 55.0% of all return appointments showed as compared to 49.1% of new appointments (p-value 0.573). Afternoon appointments had a 56.3% show rate compared to the 46.9% of morning appointments (p-value 0.364). Patients traveling greater than five miles from home had a show rate of 59.1% as compared to 52.2% of those traveling less than five miles (p-value 0.515). Private insurance users had a show rate of 62.5% as compared to 51.1% for individuals who used other methods of payment (p-value 0.541). CONCLUSIONS: Factors that may influence show rates in this underserved patient population include being a return patient, having afternoon appointment times, living greater than five miles away from clinic, and/or having private insurance. In the time interval studied, a personal reminder phone call produced a 7.0% increase in show rates. [2007 -2016 Covance Inc] were evaluated for patients with a CRS-related diagnosis. RESULTS: Seventeen efficacy (15 budesonide; 1 mometasone; 1 fluticasone) and/or safety studies (3 weeks-22 months) were identified. Most were uncontrolled (n512) versus randomized (n55); small and underpowered (< _10 subjects: n53; 11-49: n59; 50-100: n54; > _100: n51) and conducted in CRS sub-populations (eg, post-sinus surgery: n59). The 3 which were generalizable (ie, n> _50) and controlled, failed to show a statistically significant difference versus control (saline irrigation). One small study (n535) demonstrated benefit on imaging but mixed results on symptoms. Evidence of, or a trend toward, HPA axis suppression was apparent in 2/6 studies. Annual claims data showed increasing use of Budesonide RespulesÒ with increased costs (mean prescription number56 among patients with > _1 prescription; mean cost5$210/prescription). Adherence was reported to be adversely affected by third party coverage and irrigation solution preparation time, and 2.5% 6 1.6% of irrigation doses are retained in the nose. CONCLUSIONS: Evidence for efficacy of adding corticosteroid to nasal irrigations is low-quality, with reported possible benefits limited to a subpopulation with previous surgery. Adequate, well-controlled studies are needed to address dosing issues, efficacy, safety, adherence, and patient selection in order to understand the role of adding corticosteroid to nasal irrigations in CRS.
